bpc 157 and lupus BPC-157 vs. TB-500 | Peptides for sale BPC-157 | PURE POINT LABS

What are the main benefits of this product

Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences

Never spray water directly onto the lyophilized powder, as this can damage the peptide structure

Understanding the distinction between these two compounds is essential for researchers designing targeted protocols in 2026